UY34722A - Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil] etil}amino)-1-hidroxietil]-8- hidroxiquinolin-2(1h)-ona - Google Patents
Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil] etil}amino)-1-hidroxietil]-8- hidroxiquinolin-2(1h)-onaInfo
- Publication number
- UY34722A UY34722A UY0001034722A UY34722A UY34722A UY 34722 A UY34722 A UY 34722A UY 0001034722 A UY0001034722 A UY 0001034722A UY 34722 A UY34722 A UY 34722A UY 34722 A UY34722 A UY 34722A
- Authority
- UY
- Uruguay
- Prior art keywords
- phenyletoxy
- hydroxyquinolin
- ona
- difluoro
- hydroxyethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a una sal de adición, cristalina y farmacéuticamente aceptable, de (i) 5-[(1R)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil}amino)-1-hidroxietil]-8-hidroxiquinolin-2(1H)-ona, y (ii) un ácido dicarboxílico, un ácido sulfónico o una sulfimida, o un solvato farmacéuticamente aceptable de la misma.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382134.0A EP2647627A1 (en) | 2012-04-02 | 2012-04-02 | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34722A true UY34722A (es) | 2013-09-30 |
Family
ID=45926486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034722A UY34722A (es) | 2012-04-02 | 2013-04-02 | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil] etil}amino)-1-hidroxietil]-8- hidroxiquinolin-2(1h)-ona |
Country Status (20)
Country | Link |
---|---|
US (1) | US20150065471A1 (es) |
EP (2) | EP2647627A1 (es) |
JP (1) | JP2015516386A (es) |
KR (1) | KR20150002613A (es) |
CN (1) | CN104245673A (es) |
AR (1) | AR090592A1 (es) |
AU (1) | AU2013245085A1 (es) |
CA (1) | CA2862957A1 (es) |
CL (1) | CL2014002558A1 (es) |
CO (1) | CO7081156A2 (es) |
CR (1) | CR20140462A (es) |
EA (1) | EA201401084A1 (es) |
HK (1) | HK1201833A1 (es) |
IL (1) | IL234742A0 (es) |
MX (1) | MX2014010799A (es) |
PE (1) | PE20142337A1 (es) |
PH (1) | PH12014502210A1 (es) |
SG (1) | SG11201405592TA (es) |
UY (1) | UY34722A (es) |
WO (1) | WO2013149959A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2578570A1 (en) | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis. |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
ES2670025T3 (es) * | 2014-09-15 | 2018-05-29 | Verona Pharma Plc | Formulación para inhalación líquida que comprende RPL554 |
GB201502260D0 (en) * | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
EP3699163B1 (en) | 2015-03-30 | 2023-07-19 | Dow Global Technologies LLC | Integrated c3-c4 hydrocarbon dehydrogenation process |
CN104820028B (zh) * | 2015-04-21 | 2020-12-08 | 重庆医药工业研究院有限责任公司 | 一种用液相色谱法分离测定阿普斯特及其对映异构体的方法 |
EP3675909B1 (en) * | 2017-08-31 | 2023-10-18 | Charité Universitätsmedizin Berlin | Immunmodulation for prevention of poor healing of musculoskeletal injuries in compromised patients |
US10772970B2 (en) | 2017-12-01 | 2020-09-15 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
CN110407769B (zh) * | 2018-04-27 | 2022-11-08 | 复旦大学 | 3,4-二氢-苯并[f][1,4]硫氮杂䓬-5(2H)-酮类化合物及其药物用途 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT7920688V0 (it) | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore. |
EP0069715B1 (en) | 1981-07-08 | 1986-11-05 | Aktiebolaget Draco | Powder inhalator |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI69963C (fi) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | Doseringsanordning |
DE3927170A1 (de) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
IT1237118B (it) | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
DE4027391A1 (de) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
DK0503031T3 (da) | 1990-09-26 | 1999-01-04 | Pharmachemie Bv | Inhalator med et reservoir til flere doser af et materiale, der skal inhaleres |
GB9026025D0 (en) | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
CZ287848B6 (en) | 1992-12-18 | 2001-02-14 | Schering Corp | Inhalator of powder substances |
DE69617431T2 (de) | 1995-06-21 | 2002-08-01 | Asta Medica Ag | Arzneipulverkartusche mit integrierter dosiereinrichtung, sowie pulverinhalator |
OA11558A (en) * | 1999-12-08 | 2004-06-03 | Advanced Medicine Inc | Beta 2-adrenergic receptor agonists. |
DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
US6747043B2 (en) * | 2002-05-28 | 2004-06-08 | Theravance, Inc. | Alkoxy aryl β2 adrenergic receptor agonists |
ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251867B1 (es) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
WO2006014704A1 (en) * | 2004-07-21 | 2006-02-09 | Theravance, Inc. | DIARYL ETHER β2 ADRENERGIC RECEPTOR AGONISTS |
ES2302447B1 (es) * | 2006-10-20 | 2009-06-12 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
-
2012
- 2012-04-02 EP EP12382134.0A patent/EP2647627A1/en not_active Withdrawn
-
2013
- 2013-03-28 EP EP13712811.2A patent/EP2834219A1/en not_active Withdrawn
- 2013-03-28 CA CA2862957A patent/CA2862957A1/en not_active Abandoned
- 2013-03-28 EA EA201401084A patent/EA201401084A1/ru unknown
- 2013-03-28 KR KR1020147026442A patent/KR20150002613A/ko not_active Application Discontinuation
- 2013-03-28 AU AU2013245085A patent/AU2013245085A1/en not_active Abandoned
- 2013-03-28 MX MX2014010799A patent/MX2014010799A/es unknown
- 2013-03-28 US US14/389,843 patent/US20150065471A1/en not_active Abandoned
- 2013-03-28 SG SG11201405592TA patent/SG11201405592TA/en unknown
- 2013-03-28 WO PCT/EP2013/056786 patent/WO2013149959A1/en active Application Filing
- 2013-03-28 JP JP2015503838A patent/JP2015516386A/ja active Pending
- 2013-03-28 CN CN201380018953.4A patent/CN104245673A/zh active Pending
- 2013-03-28 PE PE2014001393A patent/PE20142337A1/es not_active Application Discontinuation
- 2013-04-02 UY UY0001034722A patent/UY34722A/es not_active Application Discontinuation
- 2013-04-03 AR ARP130101088A patent/AR090592A1/es unknown
-
2014
- 2014-09-18 IL IL234742A patent/IL234742A0/en unknown
- 2014-09-24 CO CO14211202A patent/CO7081156A2/es unknown
- 2014-09-25 CL CL2014002558A patent/CL2014002558A1/es unknown
- 2014-10-01 PH PH12014502210A patent/PH12014502210A1/en unknown
- 2014-10-02 CR CR20140462A patent/CR20140462A/es unknown
-
2015
- 2015-03-09 HK HK15102341.5A patent/HK1201833A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2015516386A (ja) | 2015-06-11 |
EP2834219A1 (en) | 2015-02-11 |
CL2014002558A1 (es) | 2014-11-28 |
EA201401084A1 (ru) | 2015-05-29 |
IL234742A0 (en) | 2014-11-30 |
AR090592A1 (es) | 2014-11-26 |
PE20142337A1 (es) | 2015-01-09 |
EP2647627A1 (en) | 2013-10-09 |
US20150065471A1 (en) | 2015-03-05 |
PH12014502210A1 (en) | 2015-01-12 |
HK1201833A1 (en) | 2015-09-11 |
CO7081156A2 (es) | 2014-10-10 |
CR20140462A (es) | 2014-10-31 |
AU2013245085A1 (en) | 2014-09-11 |
SG11201405592TA (en) | 2014-10-30 |
CA2862957A1 (en) | 2013-10-10 |
WO2013149959A1 (en) | 2013-10-10 |
KR20150002613A (ko) | 2015-01-07 |
CN104245673A (zh) | 2014-12-24 |
MX2014010799A (es) | 2014-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34722A (es) | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil] etil}amino)-1-hidroxietil]-8- hidroxiquinolin-2(1h)-ona | |
SMT201600057B (it) | 3,5-diammino-6-cloro-n-(n-(4-(4-(2-(esil(2,3,4,5,6-pentaidrossiesil)ammino)etossi)fenil)butil)- carbammimidoil)pirazina-2-carbossammide | |
CL2014001765A1 (es) | Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina. | |
UY34219A (es) | Compuestos de 2-(2,4,5-anilino sustituido)pirimidina | |
UY35998A (es) | 1-(3-(tert-BUTIL)1-(p-TOLIL)-1H-PIRAZOL-5-IL)-3-(4-((2-((6-ETILPIRAZIN-2-IL)AMINO)PIRIDIN-4-IL)METOXI)NAFTALEN-1-IL) UREA Y SUS SALES DERIVADAS FARMACÉUTICAMENTE ACEPTABLES, COMO INHIBIDORES DE P38 M AP QUINASA | |
UY34559A (es) | Inhibidores de bromodominios | |
UY34202A (es) | Compuestos fungicidas 2-(2-clor0-4-(4-cloro-fenoxi)-fenil]-1-(1,2,4]triazol-1-1l-etanol alquilo sustituidos | |
UY34374A (es) | Benzilindazoles sustituidos | |
UY34480A (es) | Compuestos de 2-(fenilo sustituido)-ciclopentan-1,3-diona y derivados de los mismos, composiciones y métodos para controlar malezas. | |
UY34763A (es) | Inhibidores de la agregación plaquetaria | |
CR20150061A (es) | Compuesto de pirazolopirimidinas | |
UY34352A (es) | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante | |
UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
UY34515A (es) | Triazolopiridinas sustituidas | |
UY34654A (es) | Inhibidores de la beta-secretasa | |
UY34034A (es) | Triazolopiridinas | |
UY34057A (es) | Inhibidores del virus de la hepatitis c | |
UY34006A (es) | Imidazopiridazinas | |
CL2015002309A1 (es) | Proceso de fabricacion de vortioxetina. | |
BR112014003027A2 (pt) | formulação herbicida melhorada | |
UY34498A (es) | Secante para composiciones de revestimiento auto-oxidables | |
IL248824A0 (en) | History of 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea as cxcr2 inhibitors | |
UY34329A (es) | Compuestos de triazolopiridina | |
UY33976A (es) | Derivados de pirazolo-pirimidina. | |
DK3227294T3 (da) | 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4h-pyrrolo[3,2-d]pyrimidin-4-oner som inhibitorer af myeloperoxidase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20210528 |